Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population

Arthritis and Rheumatism

Volumn 46, Issue 11, 2002, Pages 3046-3054

  Rahme, Elham ^a,d   Pettitt, Dan ^b   LeLorier, Jacques ^c  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b PFIZER INC   (United States)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; DIFLUNISAL; ETODOLAC; FENOPROFEN; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; MECLOFENAMIC ACID; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PIROXICAM; SALSALATE; SULINDAC; TIAPROFENIC ACID; TOLMETIN;

AGED; AGING; ARTHRITIS; ARTICLE; COHORT ANALYSIS; DOSE RESPONSE; DRUG SAFETY; DUODENUM ULCER; DYSPEPSIA; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; GERIATRIC PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; STOMACH ULCER;

ACETAMINOPHEN; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS; COHORT STUDIES; DRUG UTILIZATION REVIEW; FEMALE; GASTROINTESTINAL DISEASES; HOSPITALIZATION; HUMANS; MALE; PRESCRIPTIONS, DRUG; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0036847416     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10604     Document Type: Article

References (41)

1. Hochberg MC, Altman RD, Brandt KD, Clark BM, Dieppe PA, Griffin MR, et al. Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. Arthritis Rheum 1995;38:1541-6.
2. American College of Rheumatology Ad Hoc Committee on Clinical Guidelines. Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 1996;39:713-22.
3. Roth SH. NSAIDs gastropathy: A new understanding. Arch Intern Med 1996;156:1623-8.
4. Wallace JL. Nonsteroidal anti-inflammatory drugs and gastroenteropathy: The second hundred years. Gastroenterology 1997;112:1000-16.
5. Singh G, Ramey DR, Mortfeld HS, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. Arch Intern Med 1996;156:1530-6.
6. Fries JF. ARAMIS and toxicity measurement (Arthritis Rheumatism and Aging Medical Information System). J Rheumatol 1995;22:995-7.
7. Cryer B, Kimmey MB. Gastrointestinal side-effects of nonsteroidal anti-inflammatory drugs. Am J Med 1998;105 Suppl:20-30S.
8. Solomon DH, Gurwitz JH. Toxicity of nonsteroidal anti-inflammatory drugs in the elderly: Is advanced age a risk factor? Am J Med 1997;102:208-15.
9. Singh G. Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. Am J Med 1998;105 Suppl:31-8S.
10. Lanza F, Codispoti JR, Nelson EB. An endoscopic comparison of gastroduodenal injury with over-the-counter doses of keoprofen and acetaminophen. Am J Gastroenterol 1998;93:1051-4.
11. Armstrong CP, Blower AL. Non-steroidal anti-inflammatory drugs and life threatening complications of peptic ulceration. Gut 1987;28:527-32.
12. Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 1999;340:1888-99.
13. Green K, Drvota V, Vesterqvist O. Pronounced reduction in in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). Prostaglandins 1989;37:311-5.
14. Garcia Rodriguez LA, Hernandez-Diaz S. Risk of upper gastrointestinal complications among users of acetaminophen and non-steroidal anti-inflammatory drugs. Epidemiology 2001;12:570-6.
15. Locke GR III, Fett SL, Talley NJ, Zinsmeister AR, Melton LJ III. Risk factors for irritable bowel syndrome: Role of analgesics and food sensitivities. Am J Gastroenterol 2000;95:157-65.
16. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, De-Marco S, Tournier B, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 2001;345:1809-17.
17. Moore AR, van Ganse E, Le Parc JM, Wall R, Schneid H, Farhan M, et al. The PAIN Study: Paracetamol, Aspirin, Ibuprofen New tolerability. A large scale, randomised clinical trial comparing the tolerability of aspirin, ibuprofen and paracetamol for short term analgesia. Clin Drug Invest 1999;18:89-98.
18. Bradley JD, Brandt KD, Katz BP, Kalasinski LA, Ryan SI. Comparison of an antiinflammatory dose of ibuprofen, an analgesic dose of ibuprofen, and acetaminophen in the treatment of patients with osteoarthritis of the knee. N Engl J Med 1991;325:87-91.
19. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: New insights. Part I. The disease and its risk factors. Ann Intern Med 2000;133:635-46.
20. Wolfe F, Zhao S, Lane N. Preference for nonsteroidal antiinflammatory drugs over acetaminophen by rheumatic disease patients: A survey of 1,799 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Arthritis Rheum 2000;43:378-85.
21. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587-98.
22. Felson DT. The verdict favors nonsteroidal antiinflammatory drugs for treatment of osteoarthritis and a plea for more evidence on other treatments [editorial]. Arthritis Rheum 2001;44:1477-80.
23. Pincus T, Swearingen C, Cummins P, Callahan LF. Preference for nonsteroidal antiinflammatory drugs versus acetaminophen and concomitant use of both types of drugs in patients with osteoarthritis. J Rheumatol 2000;27:1020-7.
24. Silverstein FE, Graham DY, Senior JR, Davies HW, Struthers BJ, Bittman RM, et al. Misoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving non-steroidal anti-inflammatory drugs: A randomized double-blind placebo-controlled trial. Ann Intern Med 1995;123:241-9.
25. Yeomans ND, Tulassay Z, Juhasz L, Racz I, Howard JM, van Rensburg CJ, et al, Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group. A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:719-26.
26. Hawkey CJ, Karrasch JA, Szczepanski L, Walker DG, Barkun A, Swannell AJ, et al, Omeprazole verus Misoprostol for NSAID- induced Ulcer Management (OMNIUM) Study Group. Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1998;338:727-34.
27. Rahme E, Joseph L, Kong SX, Watson DJ, LeLorier J. Gastrointestinal health care resource use and costs associated with nonsteroidal antiinflammatory drugs versus acetaminophen: Retrospective cohort study of an elderly population. Arthritis Rheum 2000;43:917-24.
28. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997;127:757-63.
29. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: The accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48:999-1009.
30. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197-203.
31. Ofman JJ, MacLean CH, Straus WL, Morton SC, Berger ML, Roth EA, et al. A metaanalysis of severe upper gastrointestinal complications of nonsteroidal antiinflammatory drugs. J Rheumatol 2002;29:804-12.
32. Williams HJ, Ward JR, Egger MJ, Neumer R, Brooks RH, Clegg DO, et al. Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee. Arthritis Rheum 1993;36:1196-206.
33. Piper DW, McIntosh JH, Ariotti DE, Fenton BH, MacLennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology 1981;80:427-32.
34. Flower RJ, Vane JR. Inhibition of prostaglandin synthetase in brain explains the anti-pyretic activity of paracetamol (4-acetamidophenol). Nature 1972;240:410-1.
35. Vane JR, Botting RM. Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl 1996;102:9-21.
36. Vane JR, Botting RM. Mechanism of action in nonsteroidal anti-inflammatory drugs. Am J Med 1998;104 Suppl:2-8S.
37. Prescott LF, Mattison P, Menzies DG, Manson CM. The comparative effects of paracetamol and indomethacin on renal function in healthy female volunteers. Br J Clin Pharmacol 1990;29:403-12.
38. Berg KJ, Djoseland O, Gjeilan A, Hundal O, Knudsen ER, Rugstad HE, et al. Acute effects of paracetamol on prostaglandin synthesis and renal function. Clin Nephrol 1990;34:255-62.
39. Bipi H, Frohlich JC. Effects of acetylsalicylic acid and paracetamol alone and in combination on prostanoid synthesis in man. Br J Clin Pharmacol 1990;29:305-10.
40. Seppala E, Missila M, Isomaki H, Wuorela H, Vapaatalo H. Effects of non-steroidal and anti-inflammatory drugs and prednisolone on synovial fluid white cells, prostaglandin E2, leukotriene B4 and cyclic AMP in patients with rheumatoid arthritis. Scand J Rheumatol 1990;19:71-5.
41. Willoughby DA, Moore AR, Colville-Nash PR. COX-1, COX-2 and COX-3 and the future treatment of chronic inflammatory disease. Lancet 2000;355:646-8.